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Background: The failure rates for implementing complex innovations in healthcare organizations are high.
Estimates range from 30% to 90% depending on the scope of the organizational change involved, the definition of
failure, and the criteria to judge it. The innovation implementation framework offers a promising approach to
examine the organizational factors that determine effective implementation. To date, the utility of this framework in
a healthcare setting has been limited to qualitative studies and/or group level analyses. Therefore, the goal of this
study was to quantitatively examine this framework among individual participants in the National Cancer Institute’s
Community Clinical Oncology Program using structural equation modeling.
Methods: We examined the innovation implementation framework using structural equation modeling (SEM)
among 481 physician participants in the National Cancer Institute’s Community Clinical Oncology Program (CCOP).
The data sources included the CCOP Annual Progress Reports, surveys of CCOP physician participants and
administrators, and the American Medical Association Physician Masterfile.
Results: Overall the final model fit well. Our results demonstrated that not only did perceptions of implementation
climate have a statistically significant direct effect on implementation effectiveness, but physicians’ perceptions of
implementation climate also mediated the relationship between organizational implementation policies and
practices (IPP) and enrollment (p <0.05). In addition, physician factors such as CCOP PI status, age, radiological
oncologists, and non-oncologist specialists significantly influenced enrollment as well as CCOP organizational size
and structure, which had indirect effects on implementation effectiveness through IPP and implementation climate.
Conclusions: Overall, our results quantitatively confirmed the main relationship postulated in the innovation
implementation framework between IPP, implementation climate, and implementation effectiveness among
individual physicians. This finding is important, as although the model has been discussed within healthcare
organizations before, the studies have been predominately qualitative in nature and/or at the organizational level.
In addition, our findings have practical applications. Managers looking to increase implementation effectiveness of
an innovation should focus on creating an environment that physicians perceive as encouraging implementation.
In addition, managers should consider instituting specific organizational IPP aimed at increasing positive
perceptions of implementation climate. For example, IPP should include specific expectations, support, and rewards
for innovation use.
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Healthcare organizations continuously need to implement
complex innovations. This is truer now than ever, as the
Patient Protection and Affordable Care Act (ACA) intro-
duces innovative payment and delivery arrangements such
as Accountable Care Organizations, bundled payments,
patient-centered medical homes, and value-based pur-
chasing [1]. Unfortunately the failure rates for implemen-
ting complex innovations are high. Estimates range from
30% to 90% depending on the scope of the organizational
change involved, the definition of failure, and the criteria
to judge it [2-4]. Innovations in healthcare often fail due
in part to poor implementation, which can result from
high uncertainty, risk, and the clinical discretion required
to practice medicine. In addition, physicians tend to
strongly identify with their profession compared to their
organization, and may perceive a conflict between leader-
ship goals and workforce goals [1,5]. Additional reasons
for failure include misaligned incentives for adoption,
un-sustained leadership, lack of support and/or training,
competing priorities, and resistance to change [1,6].
Implementation failure may not only result in the loss of
time and money for the organization, but can also impact
the quality of care patients receive.
Theories of innovation implementation offer a pro-
mising approach to examine organizational factors that
influence effective implementation [7]. Specifically, the
innovation implementation framework was developed in
manufacturing, although it has been increasingly applied
to innovation implementation in healthcare [7-10]. To
date, most of the evidence supporting its use in health-
care is qualitative in nature [8,9,11-13]. Although im-
portant, qualitative studies tend to use small sample
sizes, have limited external generalizability, and present
challenges in standardizing the measurement of key con-
structs. Currently, the majority of quantitative studies
testing this framework have examined the effectiveness of
technology implementation among company employees in
information systems and computing organizations [14-20].
These settings are difficult to compare to healthcare
because: (1) physicians experience greater professional
autonomy, and (2) the process of implementing computing
technology offers greater standardization than delivering
clinical care or implementing innovative care delivery
models.
It is important to quantitatively examine the innovation
implementation framework as it will allow for a more pre-
cise examination of proposed hypotheses as well as will
allow researchers to compare results across settings, sam-
ples, and innovations. A quantitative analysis also allows
researchers to control for other explanatory variables that
may predict implementation effectiveness, which is dif-
ficult to do with qualitative research. Therefore, we quan-
titatively tested the innovation implementation frameworkin the National Cancer Institute (NCI)’s Community
Clinical Oncology Program (CCOP), a provider-based re-
search network focused on the enrollment of patients in
cancer clinical trials [21]. Using both survey and archival
data, we examined the hypothesized relationship among
core constructs of the model using structural equation
modeling (SEM). Specifically we sought to investigate the
role of implementation climate and organizational imple-
mentation policies and practices (IPP) in determining the
effectiveness of innovation implementation.
Our research extends the literature surrounding the
innovation implementation framework, as it is the first
study to quantitatively test the innovation implementa-
tion framework in a healthcare context. In addition, the
framework tested in this paper focuses on implementa-
tion among individual physicians, rather than at the
organizational or group level which is common when
testing innovation implementation models [14-16,18,22].
We were most interested in examining individual phy-
sician participation in CCOP because of the significant
variation that occurs in enrolling patients in cancer cli-
nical trials. Although all physicians agree to participate
in CCOP at some level, the number of patients enrolled by
CCOP physicians in 2011 ranged from 0 to 88 patients per
physician, with over 40% of physicians enrolling zero pa-
tients. Examining the innovation implementation frame-
work among individuals is a critical advancement given
many innovations in healthcare are implemented volun-
tarily by individual physicians. In addition, it is important
to adapt an organizational level theory to examine indivi-
dual physician enrollment because although physicians
have a level of autonomy not typically experienced in other
non-healthcare settings, they are nonetheless embedded in
a clinical context. Organizational contextual factors be-
yond an individual physician’s willingness to participate or
their desire to implement an innovation may impede their
ability to do so. Therefore, this study also has important
practical implications for implementing innovations in
complex, rapidly changing healthcare organizations.
Methods
Conceptual framework
The conceptual model for this study is based on Klein and
colleagues’ innovation implementation framework which
specifics the antecedents of complex innovation imple-
mentation [7,16]. The framework postulates that imple-
mentation effectiveness, or the consistency and quality of
innovation use, results from both organizational imple-
mentation policies and practices (IPP) and individual cli-
mate perceptions (Figure 1). IPP are the formal strategies
organizations utilize to put the innovation into use, while
implementation climate is the extent to which organiza-
tional members perceive that an innovation is expected,
supported, and rewarded by their organization [7,9,16].
Figure 1 The impact of implementation climate on physician enrollment.
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dents of climate, while individuals’ interpretive percep-
tions of climate ascribe meaning to the policies and
practices [23]. Therefore, how physicians view their or-
ganization in terms of encouraging innovation implemen-
tation is determined by IPP. In addition, these perceptions
predict the number of patients each physician will enroll
in a cancer clinical trial (i.e., implementation effective-
ness). Therefore, our first hypothesis is as follows:
H1: IPP will have a positive indirect effect on
implementation effectiveness operating through
implementation climate perceptions.
A strong implementation climate ensures organizational
members, or in this case physicians, have the skills and
support needed to implement the innovation, incentives
to participate are in place, and implementation obstacles
are limited. In this setting, strong perceptions of imple-
mentation climate should directly lead to stronger imple-
mentation effectiveness (higher patient enrollment among
physicians). We expect higher patient enrollment among
physicians with strong implementation climate percep-
tions because perceptions that a CCOP institutes enroll-
ment expectations, provides support for the enrollment of
patients, as well as recognizes enrollment efforts should
encourage physicians to enroll more patients in cancer
clinical trials. Therefore, our second hypothesis is as
follows:
H2: Perceptions of implementation climate will have a
direct positive effect on implementation
effectiveness.Given we are interested in examining an innovation
implemented by individual physicians, we needed to
modify the innovation implementation framework to en-
sure that the constructs were relevant at the individual
level [24]. For example, we were interested in examining
individual physician participation in CCOP because of
the significant variation that occurs in enrolling patients
in cancer clinical trials. Thus, we added control varia-
bles such as physician characteristics (i.e., physician age,
years of experience, specialty, practice type, training lo-
cation, and CCOP Principal Investigator (PI) status), as
we believed these characteristics would both influence
physicians’ perceptions of climate and their ability to en-
roll patients in cancer clinical trials. For example, expe-
rience and age may influence perceptions, as older and
more experienced physicians may perceive they have ac-
cess to more resources. Physician characteristics may
also impact enrollment, as more experienced physicians
or CCOP PIs may be more familiar with clinical trials
and enroll more patients. Therefore, our third hypo-
thesis is as follows:
H3: Physician characteristics will have both direct and
indirect effects on implementation effectiveness
operating through perceptions of implementation
climate.
Lastly, we included organizational control factors, such
as structure, years in existence, and size in our model. For
example, we believed larger organizations that are part of
a cancer center or research institute may have more
resources to encourage innovation implementation com-
pared to smaller, non-profit independent organizations. In
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tence longer would likely have more resources and thus
provide more trainings and offer greater incentives for
physicians to enroll patients. Therefore, our fourth hypo-
thesis is as follows:
H4: Organizational factors will have an indirect effect
on implementation effectiveness operating through
IPP and perceptions of implementation climate.
Study setting
The study was conducted in NCI’s CCOP network. In
brief, the goals of the CCOP network are to advance the
evidence-base by conducting research in clinical settings
where most people receive their care, and translate results
into better care [21,25,26]. The CCOP network is a joint
venture between NCI’s Division of Cancer Prevention,
who provides overall direction and funding for com-
munity hospitals and practices to participate in clinical
trials, selected cancer centers and clinical cooperative
groups (CCOP research bases), who design the trials, and
community-based physicians and hospitals (CCOP organi-
zations) care, who assist with patient enrollment, data
collection, and dissemination of study findings [21,25,26].
CCOP organizations are generally composed of a phy-
sician CCOP PI who provides local program leadership, a
team of support staff, as well as affiliated physicians who
enroll patients in NCI-sponsored cancer clinical trials
[8,12]. CCOP-affiliated physicians include specialized
oncologists (e.g., hematological, surgical and radiation
oncologists), general medical oncologists, and other
medical specialists (e.g., urologists, gynecologists, and
gastroenterologists).
In 2011, when the study was conducted, the CCOP
network consisted of 47 CCOP organizations across 28
states, the District of Columbia, and Puerto Rico and in-
cluded 400 hospitals and 3,520 community physicians.
CCOP organizations consisted on average of 10 commu-
nity hospitals or physician practices and 48 physicians.
This study was determined to be exempt from review by
the Institutional Review Board at the University of North
Carolina at Chapel Hill.
Data sources and data collection procedures
The data for this cross-sectional study were obtained from
four sources. First, the 2011 CCOP Annual Progress
Reports, submitted in March 2012, provided data on phy-
sicians’ enrollment activities during the period from June
1, 2011 to February 29, 2012. The reports were used to de-
termine the outcome, physician enrollment of patients in
trials. Each March, every CCOP submits a progress report
to NCI detailing the previous nine-month’s research and
enrollment activities. The report includes standardized
questions regarding the allocation of CCOP resources,staffing assignments, total cancer patient volume, the
number of open cancer clinical trials, the total number of
patients each CCOP enrolls, as well as the total number of
patients each individual CCOP-affiliated physician enrolls.
These reports are not publically available. We received
permission from the NCI Division of Cancer Prevention
to access and use these data for our study.
This study also used the 2011 CCOP Physician Survey
and the 2011 CCOP Administrator Survey, which were
both designed and administered as part of a larger NCI-
funded-study (5R01CA124402). Both surveys were re-
viewed by the Institutional Review Board at the University
of North Carolina at Chapel Hill and included instructions
for completing the survey including that completion of
the respective survey connoted consent to be a participant
in the study. The goal of the physician survey was to learn
more about physician participation in the CCOP program,
while the administrator survey collected information re-
garding CCOP policies and procedures. The physician
survey included specific questions regarding physician
perceptions surrounding expectations for enrollment, re-
search support provided by the CCOP, ability to provide
input on which clinical trials to open, how well he or she
is kept informed of CCOP activities, recognition received
from the CCOP, as well as attitudes regarding the im-
portance of cancer clinical trials. The survey specifically
supplied data on CCOP physicians’ perceptions of imple-
mentation climate.
The sampling frame for the physician survey included
all CCOP-affiliated physicians eligible to enroll patients to
clinical trials. Between October 2011 and January 2012,
we surveyed 817 physicians using a random sample stra-
tified across all 47 CCOPs. On average, 17 physicians per
CCOP were surveyed. One week after sending potential
respondents a postcard announcing the survey and high-
lighting its importance to NCI, physicians were sent a
cover letter explaining the goals of the survey, the survey
itself, a self-addressed and stamped return envelope, and a
$50 Visa gift card as an incentive to complete the survey.
Physicians were also able to complete the survey online
via a unique access code provided in the mailing. A thank-
you or reminder postcard was then sent the following
week. Approximately three weeks after the first mailing,
non-respondents received a second copy of the survey,
cover letter, and return envelope. Lastly, we contacted
CCOP PIs and administrators to email the non-responding
physicians affiliated with their CCOP requesting them to
complete the survey. The final sample included 485
physicians (59.4% of physicians surveyed). On average,
we received responses from 10 physicians per CCOP
organization.
The administrator survey included questions relating to
the CCOP’s organizational structure and size, perfor-
mance management, education and trainings, protocol
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survey specifically supplied data on CCOP’s IPP and the
organizational control factors. The survey was completed
by 100% of CCOP administrators. The vast majority of ad-
ministrators completed the survey at the 2011 annual
CCOP meeting, held each September at NCI. We followed
up via email with administrators that did not complete the
survey in person. Any remaining surveys were completed
between October 2011 and January 2012.
Lastly, the 2012 American Medical Association (AMA)
Physician Masterfile provided data for the physician char-
acteristics. Established by the AMA in 1906, the Physician
Masterfile includes current and historical data for more
than 1.4 million physicians, residents, and medical stu-
dents in the U.S, including data on demographics, spe-
cialty, experience, medical school training, and residency.
These data are available for purchase from the AMA.
Measures
The outcome of this study was implementation effective-
ness, which was operationally defined as the number of
patients that each physician enrolled in cancer clinical
trials in 2011. The NCI uses this objective, outcome-
focused measure as the primary means of determining
CCOP physician performance, as do other studies exa-
mining CCOP performance [27].
Key constructs
The organizational implementation policies and prac-
tices (IPP) construct included five measures from the
CCOP Administrator Survey, as this survey was focused
on CCOP level policies and practices that would impact
all physicians affiliated with that CCOP. As discussed,
IPP are the formal strategies organizations utilize to put
the innovation into use; they include objective assess-
ments of policies and practices the organization has in
place. To measure formal expectations for enrollment,
administrators were asked whether their CCOP expects
physicians to enroll a minimum number of patients in
clinical trials. Three measures addressed formal CCOP
support for enrollment activities: 1) proportion of phy-
sicians for whom CCOP staff members routinely screen
patient charts for potentially eligible patients; 2) pro-
portion of physicians for whom CCOP staff members
routinely assist with enrollment; and 3) whether or not
CCOP sponsor any events where physicians could learn
about the latest developments in cancer research, treat-
ment, prevention, or control. Lastly, to assess formal
rewards, administrators were asked whether the CCOP
provides some form of recognition to physicians with
high levels of enrollment to NCI-sponsored trials.
The perceptions of implementation climate construct in-
cluded six measures from the CCOP Physician Survey that
were consistent with prior studies examining perceptionsof implementation climate [7,8,12]. As discussed, imple-
mentation climate is the extent to which organizational
members perceive that an innovation is expected, sup-
ported, and rewarded by their organization. Two measures
addressed whether physicians perceived they were: 1) ex-
pected to enroll a certain number of patients in trials and
2) expected to help the CCOP meet its patient enrollment
goals. Two measures addressed whether physicians per-
ceived they get the support they needed to: 1) identify po-
tentially eligible patients and 2) enroll patients in trials.
Lastly, two measures addressed whether physicians per-
ceived they get: 1) recognition and 2) appreciation when
they enroll patients in trials. For all measures, physicians
could respond disagree, somewhat disagree, neither agree
nor disagree, somewhat agree, or agree.
Control variables
We also included both physician characteristics and
CCOP organizational factors as controls. Physician cha-
racteristics included age, whether or not they trained in
the United States, self-designated medical specialty (e.g.,
hematologist oncologist, surgeon, radiological oncolo-
gist, general oncologist, non-oncologist specialist), and
whether or not the physician was the CCOP PI. We also
included the practice arrangement (i.e., hospital-, group-,
or solo- based) and how long the physician had been in
clinical practice. The organizational factors included
CCOP organizational structure (e.g., hospital cancer cen-
ter or cancer service line, research institute, department
or center, separate non-profit organization), size (i.e.,
number of locations patients can enroll in a clinical
trial), and how long the CCOP has been in existence.
Data analysis
Structural equations modeling
SEM with maximum likelihood estimation was used to
simultaneously test whether perceptions of implemen-
tation climate mediates the relationship between IPP
and implementation effectiveness. SEM is composed of
multivariate regression models and can be used to esti-
mate proposed causal relationships [28-30]. We used
confirmatory SEM to test the hypothesized pathways
among implementation factors represented in Figure 2
by comparing how well this proposed structure fits the
observed data. We selected SEM because it allowed us
to test for constructs that are not directly assessed, but
are instead composed of observed indicators represen-
ting the constructs of interest (e.g., IPP, perceptions of
implementation climate).
The goal of SEM is to achieve a well-fitting model
based on theory [28-30]. Therefore, a priori, we believed
that the two measures that composed each of the three
components of perceptions of implementation climate
(i.e., support, reward, expectations) would co-vary higher
Figure 2 Original proposed SEM model. Note: Highlighted variables represent organizational control factors and physician control characteristics.
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the other components. For example, the two measures
that compose expectations, physicians are expected to en-
roll a certain number of patients and are expected to help
the CCOP meet its goals, likely share common variation
that is not explained by any of the proposed relationships
in the model likewise with the two measures that compose
support and the two that compose rewards. In total we
added three co-variances. We also elected to use clustered
robust standard errors to account for clustering of phy-
sicians within the 47 CCOPs.
We then evaluated model fit using the Comparative Fit
Index (CFI) and the Tucker-Lewis Index (TLI). CFI and
TLI values range from 0 to 1, with values ≥ 0.90 represen-
ting adequate fit [28,30]. We also examined the root mean
square error of approximation (RMSEA) and the associa-
ted confidence interval and p-value. RMSEA values < 0.06
and an upper bound of the confidence interval < 0.1 are
considered acceptable. Next, we examined the standardizedroot mean squared residuals (SRMR), with values < 0.08
considered acceptable fit [30].
Based on these fit statistics for the original model, we
elected to re-specify our original model to improve its
fit. SEM is an iterative process in which model fit is im-
proved by using theory and modifications indices either
to add additional pathways between variables or to allow
items to co-vary [28-30]. Modification indices are the
minimum that the chi-square statistic is expected to de-
crease if the corresponding parameter is no longer as-
sumed to be fixed at zero [28]. We added four additional
co-variances to the original model. With the addition of
each error-term co-variance, we tested whether model
fit improved by examining the baseline model against
the new model using the Lagrange multiplier test and fit
statistics.
Once we achieved a well fitting SEM model, we eva-
luated our model by testing the significance of all stan-
dardized estimates. To examine standardized direct and
Table 1 Descriptive statistics CCOP physicians

















Perceptions of implementation climate
Expectations: Enroll Patients 3.4 1.5 1,5
Expectations: Help CCOP 4.2 1.1 1,5
Support: Identify Patients 3.8 1.3 1,5
Support: Enroll Patients 4.1 1.2 1,5
Rewards: Recognition 3.2 1.3 1,5
Rewards: Appreciation 3.3 1.3 1,5
Physician characteristics included in model








Non U.S Trained 20%








*Indicates significant difference between survey respondents and
non-survey respondents.
Other race includes American Indian, Native Hawaiian/Pacific Islander, More than
one race, or unknown.
Hematology oncology includes blood banking, hematology oncology, hematology.
Radiation Oncology includes diagnostic radiology, nuclear medicine, radiation
oncology, radiology, vascular and interventional radiology.
Other specialist includes general practice, gynecological oncology, pediatrics,
pediatric hematology, cardiovascular disease etc.
Surgery includes colon and rectal surgery, critical care sugary, general surgery,
neurological surgery, surgical oncology, urological surgery etc.
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dence intervals on 1,000 bootstrap estimates. We elected
to use bootstrapping to correct for non-normality, given
the power of the joint test of two pathways in mediation
analysis is larger than the power of the test of their
product when using the usual z test and the associated
confidence intervals for the product [31]. This appears
to be due to the non-normality of the product. Spe-
cifically, indirect effects are the product of the two re-
gression coefficients. For example, if X predicts Y and Y
predicts Z, then the indirect effect of X on Z equals the
product of the two regression coefficients (X on Y and Y
on Z). Lastly, to ensure the validity of our SEM results,
we checked our results using negative binomial regres-
sion analysis with clustered robust standard errors. Ana-
lyses were performed using Mplus 7.
Results
Descriptive statistics
The final sample for this study included 481 physicians
with complete data on the 2011 CCOP-Affiliated Phy-
sician Survey (Table 1). The vast majority of the sample
was male (74%), White non-Hispanic (75%), practiced in
a group practice (78%), and trained in the U.S (80%).
The mean age was approximately 53 years old and phy-
sicians on average had been in practice approximately
26 years. Over 70% were oncology-based specialists and
9% were the CCOP PI. Physicians on average enrolled
close to five patients in a cancer clinical trial in 2011. In
addition, physicians generally agreed that their CCOP
encouraged implementation. The average response on
all six questions relating to implementation climate was
3.6 on a scale of one to five. Physicians on average rated
the two reward items the lowest (Item 1: 3.2; Item 2: 3.4)
and the expectation and support items more favorably
(Expectations item 1 & 2: 3.4 and 4.2; support items 1 &
2: 3.8 and 4.1). The only significant (p < 0.05) differences
between survey responders and non-responders were that
responders enrolled more patients per year (4.7 versus
3.4), were more likely to be a surgeon (10% versus 5%),
and were less likely to be a non-specialized general on-
cologist (11% versus 24%).
For the CCOPs (n = 47), the average number of years
in existence was over 25 (Table 2). The average size, as
determined by the number of locations a patient could
enroll in a clinical trial, was 14 and the majority of
CCOPs were a hospital cancer center or cancer service
line (40%), although 30% were a separate non-profit
organization and 24% were a research institute, depart-
ment, or center. The majority of CCOPs did not insti-
tute a minimum number of patients physicians should
enroll per year (65%), did not offer trainings or events
where physicians could learn about the latest develop-
ments in cancer research (58%), but did provide some
Table 2 Descriptive statistics CCOP organizations











Support: Identify Patients 0.51 0.32 0,1.5







Organizational factors included in model
Organizational maturity 25.5 6.2 8,30
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rollment (62%). In addition, about 50% of physicians
within a CCOP had support staff members help screen
patient charts for potentially eligible patients and assist
with enrollment.
SEM measurement analysis
The fit statistics and modification indices for the fixed pa-
rameters of the original model suggested that we re-
specify the model to improve fit (CFI = 0.846 TLI = 0.815;
RMSEA = 0.068; SRMR = 0.052) (Figure 2). Therefore, we
added four post-hoc modifications that were theoretically
justified and improved model fit (Figure 3). For these
modifications, we allowed the error terms of the following
measures to co-vary higher than with other variables. For
example, the percentage of doctors supported in screening
and enrolling patients, likely share common variation that
is not explained by any of the proposed relationships in
the model.
1) The percentage of doctors supported in screening
and enrolling patients: The same support staff
generally preform both functions within a CCOP.2) Trainings offered with the percentage doctors who
are supported in screening patients: The number of
trainings offered relates to the number of support
staff available.
3) Trainings offered with the percentage doctors who
are supported in enrolling patients: The number of
trainings offered relates to the number of support
staff available.
4) Rewards with expectations for enrollment: CCOPs
that provide incentives may also be more likely to
have expectations for enrollment.
With the addition of each error-term co-variance, we
tested whether model fit improved by examining the base-
line model against the new model using the Lagrange
multiplier test and fit statistics. Figure 3 provides a graphic
version of the final standardized bootstrapped SEM results.
Standardized bootstrapped total, direct, and indirect effects
are provided in Table 3. Overall, we achieved a final well-
fitting model (CFI = 0.933; TLI = 0.918; RMSEA = 0.045;
SRMR= 0.048) and explained approximately 24% of the
total variation in implementation effectiveness.
Regarding the IPP construct, the majority of the con-
struct was determined by expectations for enrollment
(β = 0.82), although all five measures were statistically
significant (p < 0.05). In addition, regarding the perceived
implementation climate construct, all six measures were
statistically significant determinants of the construct
(p < 0.05). The largest determinants were perceptions re-
garding the organization’s recognition and appreciation
of enrollment activities (β = 0.62; β = 0.56) as well as per-
ceptions regarding support provided to screen and enroll
eligible patients (β = 0.61; β = 0.59) (Figure 3).
SEM structural analysis: results from hypotheses testing
Hypothesis one was supported, as physicians’ perceptions
of implementation climate mediated the relationship
between IPP and enrollment. This means there was a
significant indirect effect between IPP and enrollment
operating through perceptions of implementation climate
(indirect effect = 0.069; p = 0.01) (Table 3). Although our
final model (Figure 3) indicated that implementation cli-
mate fully mediated the relationship between IPP and im-
plementation effectiveness, this model did not test for
partial mediation where IPP would also directly influence
implementation effectiveness in addition to impacting per-
ceptions of implementation climate. In our study setting,
we could also envision scenarios where IPP also directly
influenced implementation effectiveness. For example, in
addition to helping to shape perceptions of implementa-
tion climate, the number of staff available at each CCOP
to screen and enroll patients might also directly determine
the number of patients a physician was able to enroll in a
clinical trial. Although it is not included in the innovation
Figure 3 Final SEM model with standardized estimates. Note: Highlighted variables represent organizational control factors and physician
control characteristics.
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ternative model, where IPP also had a direct pathway to
implementation effectiveness (Figure 4). This alternative
model fit the data almost identically to our final model
(CFI = 0.934; TLI = 0.918; RMSEA = 0.045; SRMR= 0.047).
The standardized estimates are also the same as our final
model. The results of the alternative model do indicate,
however, that there also was a significant direct effect of
IPP on implementation effectiveness (direct effect = 0.10;
p = 0.04). Therefore, perceptions of implementation cli-
mate likely only partially mediated the relationship bet-
ween IPP and implementation effectiveness, as there was
also a direct relationship between the two constructs as
observed in the alternative model.
Returning to our final model, hypothesis two was also
supported as perceptions of implementation climate had
a statistically significant direct effect on implementationeffectiveness (direct effect = .285; p < 0.00). Hypothesis
three was partially supported given CCOP PI status, age,
radiological oncologists, and non-oncologist specialists
significantly influenced enrollment while training location,
tenure, practice location, and physicians who are sur-
geons, and hematologists (compared to non-specialized
oncologists) did not directly influence implementation ef-
fectiveness. There was no evidence, however, that any of
the physician characteristics significantly influenced im-
plementation effectiveness through their effect on percep-
tions of implementation climate. Lastly, hypothesis four
was also partially supported as organizational size and
structure indirectly influenced implementation effective-
ness through IPP and implementation climate. However,
organizational maturity did not significantly influence im-
plementation effectiveness through its effect on IPP and
perceptions of implementation climate. The robustness
Table 3 Standardized total, direct, and indirect effects
Total effect Direct effect Indirect effect
Outcome: Enrollment in NCI-Sponsored Cancer Clinical Trials in 2011
Perceptions of Implementation Climate 0.285* 0.285* N/A
Organizational Implementation Policies and Practices (IPP) 0.069* N/A 0.069*
Age −0.264* −0.179 −0.085
Hospital-Based^ −0.043 −0.066 0.023
Solo Practice^ −0.001 0.034 −0.035
Non U.S. Trained −0.035 −0.011 −0.024
PI 0.356* 0.322* 0.034
Tenure 0.224 0.117 0.107
Oncology+ −0.097 −0.075 −0.022
Radiation Oncology+ −0.162* −0.120 −0.042
Surgery+ −0.114 −0.077 −0.037
Other Specialty+ −0.147* −0.120 −0.027
Organizational Size 0.028* N/A 0.028*
Structure: Hospital Cancer Center++ 0.047* N/A 0.047*
Structure: Research Institute++ 0.016* N/A 0.016*
Structure: Other++ 0.024* N/A 0.024*
Organizational Maturity 0.000 N/A 0.000
Model Fit Statistics: CFI = 0.933; TLI = 0.918; RMSEA = 0.045; SRMR = 0.048.
Note: Total effects is the sum of direct and indirect effects.
Note: Indirect effects are the product of the regression coefficients leading to the outcome. For example for OIPP, OIPP predicts perceptions and perceptions
predicts enrollment. The indirect effect and subsequently the total effect of OIPP on enrollment equals the product of the two regression coefficients (From
Figure 3) 0.243*0.285 = 0.069.
*Statistically Significant (p < 0.05).
^Compared to Group Practice.
+Compared to General Non-Specialized Oncology.
++Compared to Separate Non-Profit Structure.
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sion analysis with clustered robust standard errors con-
firmed our main findings.
Discussion
Theoretical significance
Overall, our results quantitatively confirmed the main re-
lationship outlined in the innovation implementation
framework between IPP, perceptions of implementation
climate, and implementation effectiveness among indivi-
dual physicians [7]. It is often difficult to test this frame-
work quantitatively given the large sample of participants
and organizations required. Although the framework has
been discussed within healthcare organizations before, the
studies have been predominately qualitative in nature. For
example, Helfrich and colleagues demonstrated the rela-
tionship between IPP, implementation climate, and effec-
tiveness using comparative case studies of four cancer
clinical research networks implementing new programs in
cancer prevention and control research [9]. Similar results
have also been confirmed in other settings. Sawang andUnsworth confirmed a similar framework where imple-
mentation climate mediated the role of IPP and implemen-
tation effectiveness among small and medium businesses
implementing different innovations in Australia [18].
In addition, our results demonstrate the potential for
using the innovation implementation framework in health-
care to explain individual level innovations. Our results
confirmed that individual perceptions of implementation
climate should also be composed of measures relating to
expectations, support, and rewards, as suggested in the
innovation implementation framework [7]. Although, the
framework suggests that implementation climate should
be assessed at the group level as an aggregation of shared
perceptions, our results demonstrate that implementation
climate can also be measured at the individual level using
the same theoretical construct. Demonstrating the utility
of the framework among individuals is important given
many innovations and evidence-based practices in health-
care are implemented by individual physicians on a volun-
tary basis. For example, the use of novel therapies often
only require implementation by a single physician, not
Figure 4 Alternative SEM model with standardized estimates. Note: Highlighted variables represent organizational control factors and
physician control characteristics.
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dividuals in an organization.
Our findings are also relevant to other implementation
theories and frameworks. For example, our results can be
used in conjunction with the Consolidated Framework for
Implementation Research (CFIR). The CFIR offers gui-
dance as to the possible predictors of implementation ef-
fectiveness, such as intervention characteristics, factors at
the system and organizational levels, and characteristics of
the individuals implementing the innovation [32]. The
CFIR does not, however, provide rationale as to why some
domains may be more relevant than others and how they
are related in certain circumstances. Therefore our results
could be useful in selecting relevant constructs from
the CFIR to examine implementation effectiveness of
individually driven innovations in a healthcare setting.
For example, as part of the inner setting or organizational
level construct, the CFIR includes organizational cha-racteristics, such as size and structure, which we found to
be important determinants of organizational IPP. The
inner setting also includes policies and practices related to
implementation climate, such as organizational incentives
and rewards, clearly communicated goals and feedback,
available resources, and access to information through
trainings, all of which were included in our model as IPP
and/or in physicians’ perceptions of implementation cli-
mate. Lastly, the CFIR also includes characteristics of the
individual such as tenure, age, and experience. Our re-
search indicates how these constructs not only relate to
one another, but how they also impact implementation
effectiveness.
Practical implications
Our results demonstrated that implementation climate
perceptions partially mediated the relationship between
IPP and implementation effectiveness. Therefore, the
Jacobs et al. BMC Health Services Research  (2015) 15:6 Page 12 of 13policies and practices an organization has in place to
encourage innovation implementation may be most ef-
fective if the intended users perceive these policies and
practices as supportive. Although there was a significant
direct effect between IPP and implementation effective-
ness, over a third of the total effect of IPP on implemen-
tation effectiveness resulted from the indirect effect of
IPP on implementation effectiveness operating through
perceptions of implementation climate. Therefore, even
with supportive IPP in place, implementation could still
fail if the intended users do not feel the effects of these
IPP as encouraging implementation. In addition, the
direct relationship between implementation climate and
implementation effectiveness was almost three times
greater than the relationship between IPP and imple-
mentation effectiveness. Thus, managers looking to in-
crease implementation effectiveness of an innovation
should focus on creating an environment that physicians
perceive as encouraging implementation. For example,
ensuring physicians feel that they are supported and per-
ceive that they get what they need to effectively imple-
ment an innovation is more important than having a
certain number of staff available or offering trainings in
terms of encouraging implementation.
We also proposed that personal characteristics would
have both direct effects on implementation effectiveness
as well as indirect effects on implementation effective-
ness operating through climate perceptions. However,
we only found direct effects for some of the personal
characteristics. Although we did find that status as the
CCOP PI had a significant effect on climate perceptions,
the indirect effect operating through climate perceptions
on implementation effectiveness was not significant.
Therefore intended users that are leaders or innovation
champions may have more positive perceptions of cli-
mate compared to non-leaders. Overall, however, these
results indicate that climate perceptions were mostly de-
termined by IPP. Our findings suggest that there may be
alternative ways in which personal characteristics relate
to implementation effectiveness. For example, personal
characteristics may have an influence on fit between the
innovation and the organizational members’ values [7].
Perhaps, more experienced physicians or physicians that
have been at the organization longer perceive the in-
novation as more congruent with their individual values
and therefore use the innovation in a more consistent
and high-quality way. This should be tested in future
studies. In addition, it is possible that personal charac-
teristics moderate the relationship between implemen-
tation climate and implementation effectiveness. For
example, experience, or status as an innovation leader
may strengthen the effect of perceptions of imple-
mentation climate on implementation effectiveness. So,
experience or status as a leader would intensify therelationship between implementation climate and imple-
mentation effectiveness. Therefore, future studies should
examine other potential relationships between personal
characteristics and implementation effectiveness.Limitations
There are several limitations of our study. First, we only
included physicians who participated in CCOP in our
study. In addition, CCOP Physician Survey respondents
significantly enrolled more patients per year than survey
non-respondents. Thus, we need to be careful in gene-
ralizing our results to all CCOP physicians as well to
other types of physicians. Our findings might be most
relevant to encourage active participation in settings
where innovation use is voluntary. The framework
should also be tested in settings implementing a variety
of innovations especially where participation or imple-
mentation is mandatory. Second, our study is cross-
sectional and only represents a single point in time.
Future studies should consider examining implementa-
tion climate over the course of implementation to better
understand how climate may vary over time or among
different groups within a single organization. Lastly,
although many innovations in healthcare are focused on
the individual, we did not test the framework at the
intended unit of analysis, the organizational level. There-
fore future work should also consider investigating
this framework at the organizational or practice level
by aggregating implementation climate perceptions if
possible.Conclusion
Through this analysis we were able to extend the litera-
ture concerning the use of the innovation implementa-
tion framework as well as provide practical suggestions
for managers considering implementing an innovation.
Our study not only offers quantitative evidence that
perceptions of implementation climate mediates the re-
lationship between IPP and implementation effective-
ness, but it also demonstrates the utility of adapting
an implementation framework to explain innovations
implemented among individuals. The majority of our hy-
potheses were supported, thus demonstrating the im-
portance of physicians’ perceptions of implementation
climate in determining implementation effectiveness.
Therefore, managers looking to increase innovation im-
plementation effectiveness should consider fostering a
strong implementation climate through supportive IPP
to encourage innovation use.Competing interests
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